Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?

In the Ticlid or Plavix Post-Stents (TOPPS) trial, 1016 patients undergoing successful coronary stent placement were randomized to receive aspirin and either ticlopidine or clopidogrel. In this trial, the dosages and regimens of ticlopidine and clopidogrel resembled more closely those used in most c...

Descripción completa

Detalles Bibliográficos
Autor principal: Berger, Peter B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59605/
https://www.ncbi.nlm.nih.gov/pubmed/11714416
http://dx.doi.org/10.1186/cvm-1-2-083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59605/
https://www.ncbi.nlm.nih.gov/pubmed/11714416
http://dx.doi.org/10.1186/cvm-1-2-083

Ejemplares similares